24 results for “uk”
What is actually legal when it comes to medical cannabis in the UK? From prescriptions and possession to driving, smoking and NHS access, here’s what patients need to know about the law in 2026.
The director of the UK’s only World Anti-Doping Agency-accredited laboratory has been announced as a speaker at a medical cannabis conference in London next month.
Curaleaf Laboratories and Vericura announce a new UK medical cannabis manufacturing and distribution agreement.
How do medical cannabis vaporisers work, what are the different types, and what should UK patients know about using them safely?
Anxiety is one of the most common conditions for which medical cannabis is prescribed in the UK, but the evidence base remains mixed.
Medical cannabis costs can vary quite significantly in the UK depending on the provider, prescribed medication and clinic fees.
There remains debate within policing over how prescribed medical cannabis patients should be dealt with safely at the roadside.
Interest in medical cannabis for autism is growing among patients, families and clinicians, but research has yet to establish whether it is an effective treatment.
‘Without a clear policy, employers are more likely to be influenced by their understanding of recreational drug use.’
Ask any UK cannabis clinic which conditions bring people through the door, and ADHD will reliably be near the top of the list. Despite this demand, the published literature on […]
Pharmacist independent prescribers accounted for 61.9% of the total items prescribed between January 2019 and May 2025.
UK imports of the medical cannabis and the range of products available to patients both doubled in 2025.
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
Two years on from the legalisation of medical cannabis in Ukraine, patients have received the first legal prescriptions for cannabis-based medicines.
In a new multi-clinic survey, the majority of patients report improvements in their symptoms.
Inspectors found breaches in care, governance, and oversight at a private medical cannabis clinic.
A new UK-wide service has launched to support medical cannabis patients who face discrimination.
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
Patients and healthcare professionals have responded to recent media coverage about medical cannabis in the UK.
A new initiative is giving patients a direct voice in how the UK’s medical cannabis market is shaped.
The National Police Chiefs’ Council has approved the first official guidance for medical cannabis.
In the first of a series of deep dives in the UK market, we look into its rapid growth, the shift in dominance of popular strains, and the dramatic swing towards higher THC products.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
The authors say the guidance aims to address “clear gaps” in prescriber training and education.
